The estimated Net Worth of David J Drachman is at least $6.91 Milion dollars as of 12 September 2012. David Drachman owns over 20,000 units of Atricure Inc stock worth over $4,465,400 and over the last 19 years David sold ATRC stock worth over $2,448,473.
David has made over 13 trades of the Atricure Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently David exercised 20,000 units of ATRC stock worth $112,000 on 12 September 2012.
The largest trade David's ever made was selling 238,983 units of Atricure Inc stock on 5 September 2012 worth over $1,562,949. On average, David trades about 24,768 units every 56 days since 2005. As of 12 September 2012 David still owns at least 166,000 units of Atricure Inc stock.
You can see the complete history of David Drachman stock trades at the bottom of the page.
David's mailing address filed with the SEC is 6033 SCHUMACHER PARK DRIVE, , WEST CHESTER, OH, 45069.
Over the last 19 years, insiders at Atricure Inc have traded over $52,789,242 worth of Atricure Inc stock and bought 666,621 units worth $5,937,195 . The most active insiders traders include Scott William Drake, Group I, Llc Donoghue Danie... a Management Group Viii L L C.... On average, Atricure Inc executives and independent directors trade stock every 24 days with the average trade being worth of $548,410. The most recent stock trade was executed by Maggie Yuen on 15 August 2024, trading 3,500 units of ATRC stock currently worth $84,245.
atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.
Atricure Inc executives and other stock owners filed with the SEC include: